Immunocore Holdings (Immunocore Holdings) Price-to-Tangible-Book : 6.28 (As of May. 12, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Immunocore Holdings Price-to-Tangible-Book?

As of today (2024-05-12), Immunocore Holdings's share price is $58.95. Immunocore Holdings's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $9.39. Hence, Immunocore Holdings's Price to Tangible Book Ratio of today is 6.28.

The historical rank and industry rank for Immunocore Holdings's Price-to-Tangible-Book or its related term are showing as below:

IMCR' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 6.33 Med: 6.55 Max: 7.08
Current: 6.33

During the past 6 years, Immunocore Holdings's highest Price to Tangible Book Ratio was 7.08. The lowest was 6.33. And the median was 6.55.

IMCR's Price-to-Tangible-Book is ranked worse than
78.79% of 1221 companies
in the Biotechnology industry
Industry Median: 2.7 vs IMCR: 6.33

A closely related ratio is called PB Ratio. As of today, Immunocore Holdings's share price is $58.95. Immunocore Holdings's Book Value per Sharefor the quarter that ended in Dec. 2023 was $9.39. Hence, Immunocore Holdings's P/B Ratio of today is 6.28.

Immunocore Holdings Price-to-Tangible-Book Historical Data

The historical data trend for Immunocore Holdings's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunocore Holdings Price-to-Tangible-Book Chart

Immunocore Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

6.58

6.66

7.28

Immunocore Holdings Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial														6.66	7.20	8.39	7.15	7.28

Competitive Comparison of Immunocore Holdings's Price-to-Tangible-Book

For the Biotechnology subindustry, Immunocore Holdings's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immunocore Holdings's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunocore Holdings's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Immunocore Holdings's Price-to-Tangible-Book falls into.

Immunocore Holdings Price-to-Tangible-Book Calculation

Immunocore Holdings's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	58.95	/	9.389
	=	6.28

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Immunocore Holdings Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Immunocore Holdings's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunocore Holdings (Immunocore Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunocore Holdings PLC (NAS:IMCR) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

6YG:Germany 6YG:Germany

Address

92 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4RY

Website

https://www.immunocore.com

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.